Cardiff Oncology Inc (CRDF)

Cost of Revenue

$0.00

TTM · Period ending: · USD

CRDF logo

CRDF Cost of Revenue

Latest reported$0.00
CRDF TTM Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

CRDF cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cardiff Oncology Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
11,580,000
11,580,000
11,580,000
21,220,000
9,745,000
9,847,000
9,950,000
417,000
312,000
210,000
107,000
0
0
0
0
0
0
0
0
0
0
0
0
2,818,824
5,649,164
8,297,763
605,157,306
602,365,159
599,739,255
597,457,000
980,457
1,426,982
1,560,749
1,810,831
2,014,831
1,966,188
2,037,448
1,730,293
1,342,293
1,091,271
761,808
628,962
444,962
2,261,676
3,578,849
4,844,945
6,115,984
5,041,190
4,587,866
3,947,590
3,255,652
2,851,628
1,907,779
1,105,534
511,433
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.